BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 793497)

  • 1. Clinical course and prognosis of acute hepatitis.
    Nielsen JO
    Ann Clin Res; 1976 Jun; 8(3):151-7. PubMed ID: 793497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis A to E: symptoms, clinical aspects, prognosis].
    Maier KP
    Schweiz Rundsch Med Prax; 1992 Jun; 81(24):791-2. PubMed ID: 1604095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta antigen positive chronic liver disease in Greece: clinical aspects and natural course.
    Hadziyannis SJ
    Prog Clin Biol Res; 1983; 143():209-17. PubMed ID: 6669575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum markers of B virus in chronic active hepatitis].
    Segovia E; Rattoni N; Landa L
    Rev Gastroenterol Mex; 1981; 46(1):23-6. PubMed ID: 7280459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.
    Alberti A; Pontisso P; Chemello L; Fattovich G; Benvegnù L; Belussi F; De Mitri MS
    J Hepatol; 1995; 22(1 Suppl):38-41. PubMed ID: 7602074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.
    Knodell RG; Conrad ME; Ishak KG
    Gastroenterology; 1977 May; 72(5 Pt 1):902-9. PubMed ID: 66167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term course of sporadic non-A, non-B hepatitis: a biochemical, immunologic and histologic follow-up study].
    Altorfer J; Pirovino M; Bänninger P; Heer M; Grob PJ; Gudat F; Bianchi L; Schmid M
    Schweiz Med Wochenschr; 1983 Apr; 113(14):485-7. PubMed ID: 6443591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic evaluations during prolonged and chronic hepatitis. Significance for diagnosis and prognosis. 100 cases].
    Ribet A; Nadrigny M; Oksman F; Frexinos J
    Nouv Presse Med; 1976 Nov; 5(37):2440-3. PubMed ID: 980757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic persistent hepatitis. A clinical, serological, and prognostic study.
    Dietrichson O
    Scand J Gastroenterol; 1975; 10(3):249-55. PubMed ID: 1138326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronicity of non-A, non-B hepatitis. Evaluation of the clinical course with special reference to the types of distribution of HLA antigens and clinical criteria].
    Markus R; Baumgarten R; Fengler JD; Richter KV
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(4):121-8. PubMed ID: 6813104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
    Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
    Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: hepatitis vaccination in patients with chronic liver disease.
    Reiss G; Keeffe EB
    Aliment Pharmacol Ther; 2004 Apr; 19(7):715-27. PubMed ID: 15043512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis of acute viral hepatitis B (author's transl)].
    Platzer S; Auhuber I; Geir W; Judmaier G
    Leber Magen Darm; 1978 Apr; 8(2):83-6. PubMed ID: 634017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant hepatic failure: etiology, viral markers and outcome.
    Bendre SV; Bavdekar AR; Bhave SA; Pandit AN; Chitambar SD; Arankalle VA
    Indian Pediatr; 1999 Nov; 36(11):1107-12. PubMed ID: 10745331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute icteric viral hepatitis type A, B, D and non-A non-B. Etiologic, clinical and developmental aspects in the young man. Apropos of 423 cases].
    Molinié C; Aubert A; Boyer A; Picard J; Vergeau B; Denée JM; Farret O; Vindrios J; Buisson Y
    Gastroenterol Clin Biol; 1990; 14(3):248-54. PubMed ID: 2111781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pre S2: a marker for chronicity and/or liver damage in hepatitis B infection?].
    Brahm J; Hurtado C; Latorre R
    Rev Med Chil; 1992 Aug; 120(8):862-5. PubMed ID: 1340959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.